Biosenta Inc.
ZRO
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 101.79% | 285.71% | 0.00% | 100.00% | -199.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 101.79% | 285.71% | 0.00% | 100.00% | -199.05% |
| Cost of Revenue | 260.00% | 280.00% | -20.00% | -20.00% | 0.00% |
| Gross Profit | 100.55% | 125.00% | -25.00% | 33.33% | -199.45% |
| SG&A Expenses | 18.70% | -0.27% | 12.52% | 9.74% | -4.37% |
| Depreciation & Amortization | -11.11% | -15.79% | -40.74% | -22.73% | 5.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.75% | 0.31% | 11.65% | 8.48% | -8.19% |
| Operating Income | -1.60% | -0.12% | -11.72% | -8.46% | -28.98% |
| Income Before Tax | 0.17% | 6.19% | -5.13% | -9.38% | 63.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.17% | 6.19% | -5.13% | -9.38% | 63.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.17% | 6.19% | -5.13% | -9.38% | 63.06% |
| EBIT | -1.60% | -0.12% | -11.72% | -8.46% | -28.98% |
| EBITDA | -1.63% | -0.15% | -11.77% | -39.97% | -258.04% |
| EPS Basic | -27.61% | 11.28% | 4.77% | 5.28% | 62.43% |
| Normalized Basic EPS | -27.12% | 11.63% | 5.07% | 5.34% | -13.83% |
| EPS Diluted | -27.61% | 11.28% | 4.77% | 5.28% | 62.43% |
| Normalized Diluted EPS | -27.12% | 11.63% | 5.07% | 5.34% | -13.83% |
| Average Basic Shares Outstanding | -11.03% | 5.75% | 10.64% | 16.10% | 10.94% |
| Average Diluted Shares Outstanding | -11.03% | 5.75% | 10.64% | 16.10% | 10.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |